Skip to main content

Table 2 Clinical Characteristics and Donor-specific Data according to HCMV status in Urinary Sediment of RTX Patients. ATG antithymocyte globulin, CNI calcineurin inhibitor, DSA donor specific antibodies, D/R donor/recipient, + positive, - negative, HCMV human cytomegalovirus, IAS immunoadsorption, IQR interquartile range, n.a. not applicable, RTX renal transplantation

From: Cytomegalovirus in urinary sediment in patients with acute kidney injury

 

HCMV positive

HCMV negative

P-value

Number of subjects

10

38

 

Age (years)

56.1 ± 13.43

55.74 ± 12.82

0.938

Gender - number (%)

 Male sex

7 (70.00)

26 (68.42)

1.000

 Female sex

3 (30.00)

12 (31.58)

1.000

Donor specific data

 Donor Age (years)

58.20 ± 17.33

55.44 ± 16.14

0.638

 Cold Ischemia Time (hours)

17.56 ± 4.03

13.28 ± 5.68

0.031

 Deceased Donor - number (%)

10 (100.00)

32 (84.21)

0.320

 Living Donor - number (%)

0 (0.00)

6 (15.79)

0.320

Immunosuppression - number (%)

 CNI-based Regimen

7 (70.00)

36 (94.74)

0.054

 Belatacept-based Regimen

3 (30.00)

0 (0.00)

0.007

 Other

0 (0.00)

2 (05.26)

1.000

 History of ATG/IAS Induction Therapy

0 (0.00)

5 (13.16)

0.569

 Rejection Therapy

2 (20.00)

9 (23.68)

1.000

 Median time (IQR) after transplantation in days

94 (51 – 596)

17 (8 – 76)

0.019

Baseline DSA - number (%)

 positive

0 (0.00)

6 (15.79)

0.320

 negative

10 (100.00)

32 (84.21)

0.320

Allograft rejection - number (%)

 yes

2 (20.00)

10 (26.32)

1.000

 no

8 (80.00)

28 (73.68)

1.000

Baseline HCMV status - number (%)

 D-/R-

0 (0.00)

4 (10.53)

0.567

 D-/R+

2 (20.00)

13 (34.21)

0.472

 D+/R-

3 (30.00)

5 (13.16)

0.336

 D+/R+

5 (50.00)

16 (42.10)

0.729

HCMV- specific treatment at study timepoint - number (%)

 yes

3 (30.00)

12 (31.58)

1.000

 no

7 (70.00)

26 (68.42)

1.000

HCMV infection at study timepoint - number (%)

 yes

1 (10.00)

2 (05.26)

0.512

 no

9 (90.00)

36 (94.74)

0.512

History of HCMV infection within the previous 2 years - number (%)

 yes

2 (20.00)

3 (07.89)

0.276

 no

8 (80.00)

35 (92.11)

0.276

HCMV infection during 8-months follow up - number (%)

 yes

1 (10.00)

6 (15.79)

1.000

 no

9 (90.00)

32 (84.21)

1.000

Median (IQR) of HCMV urine sediment (copies/7mL urine)

788 (552 – 928)

n.a.

Â